EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liposomal encapsulation of a synthetic bromophenol for antitumor efficacy and apoptotic activity in cancer cells

Bercem Dilan Oztanrikulu, Ekrem Ozdemir, Bahri Avci, Süleyman Göksu, Handan Uguz Bayrakceken, Hakan Askin

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05094-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Bercem Dilan Oztanrikulu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Ataturk University, Erzurum, Turkey. Hauptthemen laut MEDLINE: Apoptosis, Antineoplastic Agents, Phenols. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Atatürk Üniversitesi, Ataturk University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel synthetic bromophenol (BP), inspired by marine-derived natural bromophenols, was evaluated for its antitumor activity and for the enhancement of its in vitro performance through liposomal encapsulation (LipoBP). Etoposide was used as a reference in characterization, release, and loading studies. PEGylated liposomes were employed to improve BP’s solubility, bioavailability, and therapeutic potential. The cytotoxicity, apoptosis, and gene expression effects of free BP and LipoBP were assessed in A549 (lung) and MCF-7 (breast) cancer cell lines. WST-8 assays showed that encapsulation significantly increased BP’s cytotoxic activity, particularly in A549 cells, while flow cytometry and Annexin V-FITC/PI analyses indicated more pronounced apoptotic induction by LipoBP compared with free BP. qRT-PCR analyses revealed upregulation of proapoptotic genes ( BAX, CASP6, CASP3 and CASP9 ) and downregulation of antiapoptotic/survival genes (BCL-XL, IQSEC2) in both cell lines, indicating activation of intrinsic apoptotic pathways. Plain liposomes exhibited minimal cytotoxicity, confirming their biocompatibility. Liposomal bromophenol, which we have introduced to the literature for the first time, is expected to be a promising nanocarrier system that could be effective in cancer treatment by improving the therapeutic index of new drug candidates such as marine bromophenols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisAntineoplastic AgentsPhenolsHumansLiposomesMCF-7 CellsA549 CellsCell Survival

Stichwörter der Autor:innen

Cancer therapyCytotoxicityDrug delivery systemLiposomal bromophenolqRT-PCR

Substanzen

LiposomesAntineoplastic AgentsPhenols

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Ataturk University, Erzurum, Turkey.
  • Department of Medical Services and Techniques, Ardahan University, Ardahan, Turkey.
  • Department of Chemical Engineering, Izmir Institute of Technology, Izmir, Turkey.
  • Department of Chemistry, Atatürk University, Erzurum, Turkey.
  • Department of Field Crops, Atatürk University, Erzurum, Turkey.
  • Department of Molecular Biology and Genetics, Ataturk University, Erzurum, Turkey. hakanbiyolog@gmail.com.

Förderung

  • Atatürk Üniversitesi
  • Ataturk University

Zitieren

APA

Oztanrikulu, B. D., Ozdemir, E., Avci, B., Göksu, S., Bayrakceken, H. U., & Askin, H. (2026). Liposomal encapsulation of a synthetic bromophenol for antitumor efficacy and apoptotic activity in cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05094-2

Vancouver

Oztanrikulu BD, Ozdemir E, Avci B, Göksu S, Bayrakceken HU, Askin H. Liposomal encapsulation of a synthetic bromophenol for antitumor efficacy and apoptotic activity in cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05094-2

BibTeX
@article{Oztanrikulu2026,
  author = {Oztanrikulu, Bercem Dilan and Ozdemir, Ekrem and Avci, Bahri and Göksu, Süleyman and Bayrakceken, Handan Uguz and Askin, Hakan},
  title = {Liposomal encapsulation of a synthetic bromophenol for antitumor efficacy and apoptotic activity in cancer cells},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05094-2}
}
Kostenlos starten →